Medicare Part D Basics for Pharmacy Technicians
Educational only, not medical advice. This guide explains general US pharmacy-technician topics. Follow your training, your pharmacist, your state board and the official references for real patients.
Medicare Part D is the outpatient prescription drug benefit for people with Medicare. For a pharmacy technician it shows up every day: in claims, in copays that change through the year, and in rejections that come with their own federal rules. The Inflation Reduction Act reshaped the benefit starting in 2025, so older study material may describe phases that no longer exist. This guide covers the current structure using figures published by CMS and Medicare.gov. Always check the current year's numbers, because several of them are adjusted annually.
Plans and formularies
Part D coverage is delivered through private plans that follow Medicare's rules. A patient gets it either from a stand-alone drug plan alongside Original Medicare or from a Medicare Advantage plan that includes drug coverage. Either way, the pharmacy bills the plan, not Medicare directly.
Each plan has its own formulary (drug list), and plans usually group drugs into tiers with different costs. Plans also use utilization tools such as prior authorization, step therapy and quantity limits. Two patients on the same drug can therefore see different copays and different rejections depending on their plan.
The coverage phases since 2025
Starting in 2025, CMS describes the standard Part D benefit as three phases: a deductible phase, an initial coverage phase and a catastrophic phase. The former coverage gap (the "donut hole") was eliminated.
| Phase | Standard benefit, 2025 | Standard benefit, 2026 |
|---|---|---|
| Deductible | Patient pays full cost until the deductible is met; maximum deductible $590 | Same structure; no plan's deductible may exceed $615 |
| Initial coverage | Patient pays 25% coinsurance until out-of-pocket spending reaches the cap | Same 25% structure |
| Out-of-pocket cap | $2,000 | $2,100 |
| Catastrophic | No cost sharing for covered Part D drugs | No cost sharing for covered Part D drugs |
A few points to keep straight:
- The table describes the standard design. Many plans have a lower or no deductible, and many use flat copays by tier instead of a 25% coinsurance.
- CMS explains the 2026 cap of $2,100 as the original $2,000 cap adjusted for growth in average Part D drug spending. Expect it to keep changing each year.
- 2027: CMS has announced the 2027 standard benefit, updated the same way: no plan's deductible may exceed $700, and the out-of-pocket cap is $2,400. The 25% initial coverage phase and the $0 catastrophic phase stay the same.
- Once the cap is reached, the patient pays nothing more for covered Part D drugs for the rest of that calendar year.
Worked example: a 25% coinsurance claim
Under the standard design, a patient has met the 2026 deductible. A covered drug's claim cost is $84.00.
- Patient share: 25% × $84.00 = 0.25 × 84.00 = $21.00
- Plan and other payers: $84.00 − $21.00 = $63.00
The $21.00 counts toward the patient's $2,100 out-of-pocket cap for 2026.
Two fixed protections worth knowing
- Insulin: a Medicare drug plan cannot charge more than $35 for a one-month supply of each covered insulin product, and the deductible does not apply.
- Adult vaccines: adult vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) have no deductible or cost sharing under Part D.
The Medicare Prescription Payment Plan
Beginning in 2025, anyone with Medicare drug coverage can choose the Medicare Prescription Payment Plan. Instead of paying out-of-pocket costs at the counter, the patient pays $0 at the pharmacy for covered drugs and gets a monthly bill from the plan. It does not lower the total amount owed; it spreads it across the year. Patients sign up through their plan, before the year starts or at any time during it. Starting in 2026, the plan renews a patient's participation automatically each year, and the patient can opt out at any time. CMS notes it tends to help most when large costs come early in the year.
The plan works out each monthly bill with a set formula. "Months left" always counts the current month.
- First month in the plan: the bill is the patient's actual out-of-pocket costs that month or a cap, whichever is less. The cap is the year's out-of-pocket limit, minus anything already counted toward it earlier in the year, divided by the months left. For someone who joins for January 2026 with no earlier costs, the cap is $2,100 ÷ 12 = $175.
- Every month after that: the costs not yet billed plus any new out-of-pocket costs, divided by the months left.
- A patient who has no costs yet gets no bill.
Worked example: monthly bill
A patient joins for January 2026 with no earlier costs and has a $1,275 out-of-pocket cost in January.
- January (first month): the cap is $2,100 ÷ 12 months = $175. The bill is the lesser of $1,275 and $175, so $175. Not yet billed: $1,275 − $175 = $1,100.
- February: $1,100 ÷ 11 months left (February–December) = $100. If nothing new is filled, each month stays at $100. After five payments (February–June), $1,100 − (5 × $100) = $600 is not yet billed.
- In July, a new $300 cost is added: $600 + $300 = $900, divided by 6 months left (July–December) = $150 per month.
- Check: $175 + (5 × $100) + (6 × $150) = $175 + $500 + $900 = $1,575 = $1,275 + $300.
CMS also requires plans to alert the pharmacy, through the claim response, when a patient who is not in the payment plan has $600 or more in out-of-pocket costs for a single covered drug (plans may add their own criteria). The pharmacy must then let the patient know they are likely to benefit. In a community pharmacy, that means giving the patient a paper copy of the "Medicare Prescription Payment Plan Likely to Benefit Notice" at pickup. Plans don't have to send this alert in December. Follow your pharmacy's procedure for that notice.
Coverage determinations and exceptions
A coverage determination is the plan's decision about whether it will cover a drug, and how much the patient pays. The patient, their representative or their prescriber can request one, orally or in writing (a request to be paid back for a drug already bought must be in writing unless the plan accepts oral requests). Under 42 CFR Part 423 Subpart M:
- A standard decision is due no later than 72 hours after the plan receives the request.
- An expedited decision is due no later than 24 hours. The patient or the prescriber can ask for one. The plan must expedite it when the prescriber indicates, or the plan decides, that waiting could seriously jeopardize the patient's life, health or ability to regain maximum function.
- For exception requests, the clock starts when the plan receives the prescriber's supporting statement.
Two kinds of exceptions come up often:
- A formulary exception asks the plan to cover a drug that is not on its list, or to waive a coverage rule such as a quantity limit.
- A tiering exception asks the plan to charge a lower tier's cost sharing for a drug on a higher tier.
A decision on whether the patient has met a prior authorization requirement is also a coverage determination. If the plan says no, the patient can appeal; the first level is a redetermination by the plan.
Transition fills
People who are new to a plan may already be taking a drug that the new plan does not cover or that needs prior authorization or step therapy. Federal rules require plans to provide a transition supply during the first 90 days of coverage under a new plan: a one-time, temporary supply of at least a month's supply. Under 42 CFR 423.120(b)(3), the fill must be at least an approved month's supply; if the prescription is written for less, the plan must allow multiple fills up to a total of an approved month's supply. (The older CMS manual describes the outpatient minimum as 30 days.) Transition rules also apply to current members whose drug is affected by a formulary change. Long-term care residents have different transition rules. The point is to give the patient and prescriber time to switch drugs or request an exception without a gap in therapy.
The notice when a claim can't be covered
When a Part D prescription cannot be filled under the benefit and the problem cannot be resolved at the point of sale, federal rules (42 CFR 423.562(a)(3)) require Part D plans to arrange for their network pharmacies to give the patient the standardized notice "Medicare Drug Coverage and Your Rights" (CMS-10147), often called the pharmacy notice. (Older versions, and some CMS guidance, use the title "Medicare Prescription Drug Coverage and Your Rights.") The plan's claim response tells the pharmacy when the notice applies. Some rejections, such as refill too soon or a claim missing required information, don't call for the notice. The notice explains how to contact the plan and the patient's right to request a coverage determination, including an exception. The pharmacy must give the patient a written copy, and plans may not change its content.
For the technician, the practical rule is: when the claim response says the notice applies, never just hand back the prescription. Give the patient a copy of the notice, explain that the patient or prescriber can ask the plan for a decision, and involve the pharmacist.
Key takeaways
- Since 2025, standard Part D has three phases: deductible, initial coverage and catastrophic. The coverage gap is gone.
- The out-of-pocket cap was $2,000 in 2025, is $2,100 in 2026 and will be $2,400 in 2027; after it, covered drugs cost the patient $0.
- The Medicare Prescription Payment Plan spreads out-of-pocket costs into monthly bills but does not reduce them.
- Coverage determinations are due in 72 hours (standard) or 24 hours (expedited); exceptions start from the prescriber's statement.
- New enrollees get a transition supply during their first 90 days.
- When a Part D claim can't be covered, the patient gets the CMS-10147 rights notice.
Quick check
Q1. What are the three phases of the standard Part D benefit in 2026? Answer: Deductible, initial coverage and catastrophic. The coverage gap was eliminated starting in 2025.
Q2. A patient who joined the payment plan earlier in the year has $900 in costs not yet billed at the start of July, and nothing new is filled. What is the July bill? Answer: $150. $900 ÷ 6 months left (July–December, counting July) = $150.
Q3. A Part D claim rejects and cannot be resolved at the counter. What federal notice does the patient receive? Answer: "Medicare Drug Coverage and Your Rights" (CMS-10147). It explains how to request a coverage determination from the plan.
You can practice these in Pillworks Idle.
Sources
- CMS — Final CY 2025 Part D Redesign Program Instructions Fact Sheet
- CMS — Final CY 2026 Part D Redesign Program Instructions
- Medicare.gov — How much does Medicare drug coverage cost?
- Medicare.gov — What's the Medicare Prescription Payment Plan?
- Medicare.gov — Appeals in a Medicare drug plan
- eCFR — 42 CFR Part 423 Subpart M (Coverage Determinations, Redeterminations)
- CMS — Medicare Prescription Drug Benefit Manual, Chapter 6
- CMS — Plan Sponsor Notices and Other Documents (Medicare Drug Coverage and Your Rights, CMS-10147)
- CMS — CY 2027 Rate Announcement (Part D benefit parameters, Table V-2)
- eCFR — 42 CFR 423.137 (Medicare Prescription Payment Plan)
- eCFR — 42 CFR 423.120 (Formularies and transition process)